Kura Oncology (KURA) Interest Coverage Ratio (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -141.03% |
| Dec 31, 2025 | 404.73% |
| Sep 30, 2025 | -11.59% |
| Jun 30, 2025 | 0.74% |
| Mar 31, 2025 | -306.39% |
| Dec 31, 2024 | 68.20% |
| Sep 30, 2024 | -5.50% |
| Jun 30, 2024 | -0.63% |
| Dec 31, 2014 | 90.78% |
| Sep 30, 2014 | 10.16% |
| Jun 30, 2014 | -25.37% |
| Mar 31, 2014 | 47.73% |
| Dec 31, 2013 | -80.82% |
| Sep 30, 2013 | 36.27% |
| Jun 30, 2013 | -12.47% |
| Mar 31, 2013 | 42.40% |
| Dec 31, 2012 | -77.02% |
| Sep 30, 2012 | 6.32% |
| Jun 30, 2012 | -4.74% |
| Mar 31, 2012 | 57.31% |
| Dec 31, 2011 | -48.64% |
| Sep 30, 2011 | 9.08% |
| Jun 30, 2011 | -35.30% |
| Mar 31, 2011 | 64.57% |
| Dec 31, 2010 | -69.26% |